Overview

Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise

Status:
Completed
Trial end date:
2016-01-25
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the pharmacokinetic and adhesion performance of ZTlido (lidocaine topical system) 1.8% during physical exercise, application of heat, and under normal conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Scilex Pharmaceuticals, Inc.
Treatments:
Lidocaine